Skip to content Skip to footer
Subscribe Now

TOP 20

Vaccines Based Top 20 2022
Top 20 Vaccines Based on 2022 Total Revenue
Shots:Driven by a noble pursuit to ensure global health security, vaccines cater to the healthcare needs of millions and billions of people. With an instrumental role in containing the COVID-19 pandemic, immunization prevents more than 5 million deaths annually from conditions like diphtheria, tetanus, pertussis, influenza, and measlesWith a global market size of…
July 25, 2023
Innovative Digital Therapeutics Top 20 2022
Top Innovative Digital Therapeutics Companies of 2022
Shots:Transforming lives by leveraging cutting-edge technological advances, digital health companies have embarked on a journey to reshape the way we see and experience therapeuticsDigital health companies are fostering the use of highly innovative technologies in the healthcare system. In 2021, the global digital health therapeutics market was valued at $3.8B and is envisioned…
July 12, 2023
Nutraceutical Top 20 2022
Top 20 Nutraceutical Companies Based on 2022 Segment Revenue 
Shots:  On the trail of a healthy lifestyle, nutraceuticals have a crucial role to play. A portmanteau of nutrients and pharmaceuticals, nutraceuticals are colloquially known as medical foodsWith a market size of $413B in 2021, the nutraceutical market value is forecasted to cross the threshold of $650B by 2030 by marking a remarkable CAGR…
June 29, 2023
Diagnostics Top 20 2022
Top 20 Diagnostics Companies Based on 2022 Total Revenue
Shots:Impelled by interminable technological advances and unceasing innovations, diagnostic and testing companies hold potent positions in the healthcare industry. The diagnostic and testing companies have been serving as a pivotal foundation stone of the healthcare sectorWith a global market value of $165.58B in 2021, the diagnostic and testing market size is anticipated to…
June 14, 2023
Cell and Gene Therapy Top 20 2022
Top 20 Cell and Gene Therapy Companies Based on 2022 Total Revenue
Shots:Standing tall and gradually paving its way through extensive research, Cell & Gene Therapy is a beacon of hope when treating rare and inherited diseases. Cell and gene therapy aims to prevent, treat, and potentially reduce the effects of the underlying cause of genetic diseases.Propelled by constant innovatory winds, the cell and gene…
May 23, 2023
Medical Device Top 20 2022
Top 20 Medical Device Companies Based on 2022 Total Revenue
Shots:Driven by constant innovation and life-changing technological advances, medical device companies have integrated a holistic approach to diagnosis and therapeutics. Bolstered by the inch-perfect result and cutting-edge technology, gradually medical devices have got profoundly embedded in our livesWith a global market value of $562.6B in 2022, medical device companies are anticipated to touch…
May 10, 2023
RNAi Therapeutic Top 20 2022
Top 20 RNAi Therapeutic Companies Based on 2022 R&D Expenditure
Shots:RNAi Therapeutic leverages the biological response of degrading (mRNA) before it gets translated into a protein. By using short double-stranded RNA in silencing a targeted disease-causing mutation, researchers are working steadfastly in multiple indications to expand RNAi therapeuticRNAi therapy comes to the rescue when targeting a specific protein gets difficult using a conventional…
April 25, 2023
BioPharma Top 20 2022
Top 20 BioPharma Companies based on 2022 Total Revenue
Shots:Biopharma companies have kept themselves afloat in the ocean of uncertainties by overcoming the hurdles of unmet demands, procurement, and maintaining a constant supply chain. However, the previous year was difficult for biopharma companies as the segment saw multiple insolvencies.Amidst all kinds of obstacles, many companies have sustained themselves to meet the market…
April 12, 2023
Drugs Top 20 2023
Top 20 Drugs with US Patent Expiry in 2023 Based on Total Sales Value
Shots:Drug patent expiry is when a patent granted to a pharmaceutical company for a particular drug expires, allowing other companies to produce and sell generic versionsLike every other utility patent, pharmaceuticals also get market exclusivity of 20 years. Some companies accept the offered period and open doors to biological drugs or biosimilars. In…
March 29, 2023
Top 20 Biopharma Deal Terminations of 2022 Based on Total Deal Value
Top 20 Biopharma Deal Terminations of 2022 Based on Total Deal Value
Shots:Post M&A deals, companies often cannot sail through a few key aspects of the partnership, such as limited ownership, exorbitant recovery costs, and poor integration process, leading to deal terminations. The improperly executed expansion program also contributes significantly to the failed partnershipTo tackle such scenarios, companies are cautious enough to make backup plans beforehand…
March 22, 2023
Load more